Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia

Claudie Bosc, Estelle Saland, Aurélie Bousard, Noémie Gadaud, Marie Sabatier, Guillaume Cognet, Thomas Farge, Emeline Boët, Mathilde Gotanègre, Nesrine Aroua, Pierre‐Luc Mouchel, Nathaniel Polley, Clément Larrue, Éléonore Kaphan, Muriel Picard, Ambrine Sahal, Latifa Jarrou, Marie Tosolini, Florian Rambow, Florence Cabon, Nathalie Nicot, Laura Poillet-Perez, Yujue Wang, Xiaoyang Su, Quentin Fovez, Jérôme Kluza, Rafael J. Argüello, Céline Mazzotti, Hervé Avet‐Loiseau, François Vergez, Jérôme Tamburini, Jean‐Jacques Fournié, Ing Soo Tiong, Andrew H. Wei, Tony Kaoma, Jean‐Christophe Marine, Christian Récher, Lucille Stuani, Carine Joffre, Jean‐Emmanuel Sarry